Skip to content

H2020FP7HORIZON

Bundesinstitut fur Impfstoffe und Biomedizinische Arzneimittel

Country
DEGermany
Defence projects
0
Projects, all programmes
24
As coordinator
0
EU contribution (CORDIS)
EUR 9,754,787
Active
2009 to 2025

Projects

24 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
VIROMARKERSVirus related biomarkers to improve management of chronic conditionsHORIZON2025ParticipantEUR 85,625
ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCEHORIZON2024ParticipantEUR 128,535
ECOWAS-RegECsPractical strengthening of regulatory and ethics oversight on clinical trials in West Africa using Lassa Fever vaccine development projects and increase regulatory maturity level in targeted countriesHORIZON2023ParticipantEUR 0
ALLPreTAllergenicity Prediction Toolbox for novel foodsHORIZON2022ParticipantEUR 260,539
EuroGCTEuropean consortium for communicating gene- and cell-based therapy information.H20202021ParticipantEUR 0
Inno4VacInnovations to accelerate vaccine development and manufactureH20202021ParticipantEUR 437,131
T2EVOLVEAccelerating Development and Improving Access to CAR and TCR-engineered T cell therapyH20202021ParticipantEUR 479,000
T-OPTraining Network for Optimizing Adoptive T cell Therapy of CancerH20202021ParticipantEUR 252,788
TIPATTraining towards Personalized Antibiotic TreatmentH20202020ParticipantEUR 505,577
EU-PEARLEU Patient- cEntric clinicAl tRial pLatformH20202019ParticipantEUR 317,625
STACCATOEuropean Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysisH20202019ParticipantEUR 505,577
STARSStrengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)H20202019ParticipantEUR 190,000
COMBINECollaboration for Prevention and Treatment of MDR Bacterial InfectionsH20202019ParticipantEUR 1,466,860
imSAVARImmune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapiesH20202019ParticipantEUR 602,556
CARAMBASLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic diseaseH20202018ParticipantEUR 342,875
CCHFVaccineCrimean-Congo Haemorrhagic Fever VaccineH20202017ParticipantEUR 136,000
CARATChimeric Antigen Receptors (CARs) for Advanced TherapiesH20202016ParticipantEUR 715,534
VAC2VACVaccine lot to Vaccine lot comparison by consistency testing.H20202016ParticipantEUR 1,000,000
TBVAC2020TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical developmentH20202015ParticipantEUR 0
FLUCOPStandardization and Development of Assays for Assessment of Influenza Vaccines Correlates of ProtectionFP72015ParticipantEUR 632,006

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.